Neil Savage
Abstract
With the right approach, data mining can discover unexpected side effects and drug interactions.
- Altman, R. Russ Altman @ PMWC 2012: Data Mining EMR's, http://www.youtube.com/ watch?v=XPBrCYaV050, Feb. 24, 2012.Google Scholar
- Harpaz, R., DuMouchel, W., Shah, N.H., Ryan, P., and Friedman, C. Novel data mining methodologies for adverse drug even discovery and analysis, Clinical Pharmacology and Therapeutics, May 2, 2012.Google Scholar
- Hopstadius, J., and Noren, G.N. Robust discovery of local patterns: subsets and stratification in adverse drug reaction surveillance, 2012 ACM SIGHIT International Health Informatics Symposium, Miami, FL, Jan. 28-30, 2012. Google ScholarDigital Library
- Lounkine, E., et al. Large-scale prediction and testing of drug activity on side-effect targets, Nature 486, 7403, June 10, 2012.Google ScholarCross Ref
- Tatonetti, N.P., Ye, P.P., Daneshjou, R., and Altman, R. Data-driven prediction of drug events and interactions, Science Translational Medicine 4, 125, March 14, 2012.Google ScholarCross Ref
Index Terms
- Digging for drug facts
Recommendations
Drug Repurposing: Targeting mTOR Inhibitors for Anticancer Activity
CSBio '17: Proceedings of the 8th International Conference on Computational Systems-Biology and BioinformaticsIn the search of safer and more effective drugs while reducing costs and increasing productivity of novel drug discovery, scientists are changing their focus to an approach known as drug repurposing. This involves finding a new therapeutic effect of an ...
Drug promiscuity: Exploring the polypharmacology potential of 1, 3, 6-trisubstituted 1, 4-diazepane-7-ones as an inhibitor of the ‘god father’ of immune checkpoint
Graphical abstractDisplay Omitted
Highlights- We used the similarities in the binding site of unsimilar proteins to repurpose an existing inhibitor.
AbstractHigh production cost, instability, low tumor penetration are some of the shortcomings that have characterized and undermined the use of antibodies as a target for Cytotoxic T-lymphocytes associated protein 4 (CTLA-4). Design and ...
A multidrug efflux protein in Mycobacterium tuberculosis; tap as a potential drug target for drug repurposing
AbstractTuberculosis (TB) is a serious communicative disease caused by Mycobacterium tuberculosis. Although there are vaccines and drugs available to treat the disease, they are not efficient, moreover, multidrug-resistant ...
Graphical abstractDisplay Omitted
Highlights- Tuberculosis (TB) is a serious communicative disease caused by M. tuberculosis.
Comments